CKD Trademark

Serial Number: 79420083

CKD is a trademark filed by Mitsubishi Tanabe Pharma Corporation on January 28, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 40 - Treatment & Processing

Treatment of materials

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Mitsubishi Tanabe Pharma Corporation

3-2-10, Dosho-machi,

Entity Type: 03

Legal Representation

Attorney of Record

Alexis P. Grilli

422 trademarks filed View all →

Correspondence Address

Alexis P. Grilli Nixon Peabody LLP

799 9th Street, NW, Suite 500

Washington, DC 20001

United States

Trademark Details

Filing Date

January 28, 2025

Registration Date

Not Registered

Goods & Services

Testing, inspection or research of pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; consulting services in the field of testing, inspection or research of pharmaceuticals namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; providing scientific information about medical testing of pharmaceuticals, and providing medical and scientific testing, inspection and research information in the field of pharmaceuticals namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; Medical and scientific research, namely, conducting clinical trials for pharmaceuticals in the field of targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; research and development services in the field of pharmaceutical preparations namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases

Custom manufacture of pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases

Pharmaceutical preparations, namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; pharmaceuticals namely targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; medicines for human purposes namely, targeted protein degrader for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases; target protein degrader namely, pharmaceutical preparations for the treatment, prevention and alleviation of oncologic, immunologic, inflammatory diseases